RxDoctor Payments Data

Daniel Nekola

Anesthesiology · Massapequa, NYNPI 1316289788

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,598 of the $6,229 with a category attached, or 73.8%. Pacira Pharmaceuticals Incorporated accounts for 73.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $4,598 and has fallen 87.7% since, to $564 in 2025. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,229in general payments, 2019–2025

Across 23 payments — averaging $270.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$5K
  • Hemosonics LLC$908
  • CSL Behring$386
  • Haemonetics Corporation$166
  • Octapharma USA, Inc.$108
  • Lilly USA, LLC$40
  • plus $25 from 1 others

What the payments were for

  • Speaking & faculty fees$4,59874%
  • Food & beverage$1,63126%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,229 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.

See all anesthesiology providers in New York →

Medicare billing

Part B allowed, 2024
$51,650
Medicare patients
146
Services billed
189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Massapequa

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →